Published in Angiologica on January 01, 1967
A fine structural study of the removal of the effectiveness of benzo-pyrone treatment of lymphoedema by the destruction of the macrophages by silica. Br J Exp Pathol (1978) 0.77
[Changes of the neck skin following ligation of the cervical lymph ducts]. Arch Klin Exp Dermatol (1968) 0.77
Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature (2000) 5.86
EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria. Allergy (2009) 4.10
EAACI/GA(2)LEN/EDF/WAO guideline: management of urticaria. Allergy (2009) 3.86
CENP-C, an autoantigen in scleroderma, is a component of the human inner kinetochore plate. Cell (1992) 3.70
The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. Allergy (2014) 3.10
A comprehensive guide for the recognition and classification of distinct stages of hair follicle morphogenesis. J Invest Dermatol (1999) 2.92
Treatment of lymphedema. Lymphology (1994) 2.33
Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. J Allergy Clin Immunol (2012) 2.17
Home versus hospital deliveries: follow up study of matched pairs for procedures and outcome. Zurich Study Team. BMJ (1996) 2.10
American Cancer Society Lymphedema Workshop. Workgroup III: Diagnosis and management of lymphedema. Cancer (1998) 2.06
Conservative treatment of lymphoedema of the limbs. Angiology (1985) 1.89
Mast cells as sentinels of innate immunity. Curr Opin Immunol (1999) 1.85
Factors responsible for differences between asymptomatic subjects and patients presenting an IgE sensitization to allergens. A GA2LEN project. Allergy (2006) 1.84
Impaired mast cell-dependent natural immunity in complement C3-deficient mice. Nature (1997) 1.78
EAACI/GA(2)LEN task force consensus report: the autologous serum skin test in urticaria. Allergy (2009) 1.65
Autologous whole blood injections to patients with chronic urticaria and a positive autologous serum skin test: a placebo-controlled trial. Dermatology (2006) 1.65
Molecular cloning, chromosome mapping and characterization of UBQLN3 a testis-specific gene that contains an ubiquitin-like domain. Gene (2000) 1.57
How to assess disease activity in patients with chronic urticaria? Allergy (2008) 1.55
EAACI/GA2LEN/EDF guideline: definition, classification and diagnosis of urticaria. Allergy (2006) 1.55
Membrane physical state controls the signaling mechanism of the heat shock response in Synechocystis PCC 6803: identification of hsp17 as a "fluidity gene". Proc Natl Acad Sci U S A (1998) 1.54
Embolization of biologic glue during repair of aortic dissection. Ann Thorac Surg (1995) 1.52
How best to fight that nasty itch - from new insights into the neuroimmunological, neuroendocrine, and neurophysiological bases of pruritus to novel therapeutic approaches. Exp Dermatol (2005) 1.51
Control of murine hair follicle regression (catagen) by TGF-beta1 in vivo. FASEB J (2000) 1.48
A soluble class II cytokine receptor, IL-22RA2, is a naturally occurring IL-22 antagonist. Proc Natl Acad Sci U S A (2001) 1.43
Risk of first-generation H(1)-antihistamines: a GA(2)LEN position paper. Allergy (2010) 1.42
Fatal recurrent subarachnoid hemorrhage after complete endovascular aneurysm occlusion. AJNR Am J Neuroradiol (2006) 1.40
The definition and diagnostic testing of physical and cholinergic urticarias--EAACI/GA2LEN/EDF/UNEV consensus panel recommendations. Allergy (2009) 1.39
[Idiopathic facial palsy during pregnancy]. HNO (2012) 1.38
Lymphogenic haemangiopathy. "Prelymphatic" pathways in the wall of cerebral and cervical blood vessels. Angiologica (1968) 1.37
On the pathophysiology of arm lymphedema after treatment for breast cancer. Lymphology (1995) 1.35
Schnitzler's syndrome: diagnosis, treatment, and follow-up. Allergy (2013) 1.35
The lymphedema chaos: a lancet. Ann Plast Surg (1989) 1.34
NMR solution structure of a complex of calmodulin with a binding peptide of the Ca2+ pump. Biochemistry (1999) 1.33
Identification of a novel class of genomic DNA-binding sites suggests a mechanism for selectivity in target gene activation by the tumor suppressor protein p53. Genes Dev (1998) 1.31
p53 is essential for chemotherapy-induced hair loss. Cancer Res (2000) 1.29
EAACI/GA2LEN/EDF guideline: management of urticaria. Allergy (2006) 1.28
Melanogenesis during the anagen-catagen-telogen transformation of the murine hair cycle. J Invest Dermatol (1994) 1.27
A simultaneous (15)N, (1)H- and (13)C, (1)H-HSQC with sensitivity enhancement and a heteronuclear gradient echo. J Biomol NMR (1995) 1.25
Impaired mast cell development and innate immunity in Mac-1 (CD11b/CD18, CR3)-deficient mice. J Immunol (1998) 1.25
Quality of life in patients with chronic urticaria is differentially impaired and determined by psychiatric comorbidity. Br J Dermatol (2006) 1.24
Polarity of microtubule assemblies during neuronal cell migration. Proc Natl Acad Sci U S A (1996) 1.23
Selective degeneration by capsaicin of a subpopulation of primary sensory neurons in the adult rat. Neurosci Lett (1985) 1.22
Modulation of chloroplast membrane lipids by homogeneous catalytic hydrogenation. Eur J Biochem (1985) 1.22
Characterization of functional vanilloid receptors expressed by mast cells. Blood (1998) 1.21
p53 Involvement in the control of murine hair follicle regression. Am J Pathol (2001) 1.19
Modulation of the blood-brain barrier permeability in neonatal cytotoxic brain edema: laboratory and morphological findings obtained on newborn piglets with experimental pneumothorax. Biol Neonate (1984) 1.17
Methods report on the development of the 2013 revision and update of the EAACI/GA2 LEN/EDF/WAO guideline for the definition, classification, diagnosis, and management of urticaria. Allergy (2014) 1.16
Re-engineering the toilet for sustainable waste water management. Environ Sci Technol (2001) 1.14
Effects of histamine on brain capillaries. Fine structural and immunohistochemical studies after intracarotid infusion. Exp Brain Res (1982) 1.14
Rupatadine in allergic rhinitis and chronic urticaria. Allergy (2008) 1.13
Exposure of tumor necrosis factor-alpha to luminal membrane of bovine brain capillary endothelial cells cocultured with astrocytes induces a delayed increase of permeability and cytoplasmic stress fiber formation of actin. J Neurosci Res (1995) 1.13
Epidemiology of urticaria: a representative cross-sectional population survey. Clin Exp Dermatol (2010) 1.12
Ultrastructural evidence for altered calcium in motor nerve terminals in amyotropic lateral sclerosis. Ann Neurol (1996) 1.12
Renal involvement in patients with primary Sjögren's syndrome. Scand J Rheumatol (1989) 1.11
Antibacterial effects of cefroxadine, cephalexin and cephradine in a new in vitro pharmacokinetic model. J Antibiot (Tokyo) (1982) 1.11
Up-dosing with bilastine results in improved effectiveness in cold contact urticaria. Allergy (2013) 1.09
Polyspecific, antiviral immune response distinguishes multiple sclerosis and neuromyelitis optica. J Neurol Neurosurg Psychiatry (2008) 1.08
[On the "yellow finger-nail syndrome"]. Z Klin Med (1965) 1.07
The German version of the Chronic Urticaria Quality-of-Life Questionnaire: factor analysis, validation, and initial clinical findings. Allergy (2009) 1.07
Mast cell involvement in murine hair growth. Dev Biol (1994) 1.06
New contributions to the anatomical connections of the brain and the lymphatic system. Acta Anat (Basel) (1966) 1.05
Cytotoxic drug-induced, p53-mediated upregulation of caspase-8 in tumor cells. Oncogene (2007) 1.04
Successful treatment of cholinergic urticaria with anti-immunoglobulin E therapy. Allergy (2008) 1.04
Separation of acetylcholine and catecholamine containing synaptic vesicles from brain cortex. J Neurochem (1977) 1.04
Mitochondrial alterations in the spinal ganglion cells of the rat accompanying the long-lasting sensory disturbance induced by capsaicin. Life Sci (1969) 1.03
The effects of norepinephrine and angiotensine on the lymphatic system. Med Pharmacol Exp Int J Exp Med (1966) 1.02
Mast cells as initiators of immunity and host defense. Exp Dermatol (2001) 1.02
Studies on a capillary-rich fraction isolated from brain: histaminic components and characterization of the histamine receptors linked to adenylate cyclase. J Neurochem (1980) 1.02
Effectiveness of a procalcitonin algorithm to guide antibiotic therapy in respiratory tract infections outside of study conditions: a post-study survey. Eur J Clin Microbiol Infect Dis (2009) 1.01
Strategies for improvement of awareness, treatment and control of hypertension: results of a panel discussion. J Hum Hypertens (2004) 1.01
A procedure for the isolation of capillaries from rat brain. Cytobios (1974) 1.00
Matrix metalloproteinase-9: a novel biomarker for monitoring disease activity in patients with chronic urticaria patients? Allergy (2009) 1.00
Potential immunocompetence of proteolytic fragments produced by proteasomes before evolution of the vertebrate immune system. J Exp Med (1997) 1.00
PLUSH TACSY: Homonuclear planar TACSY with two-band selective shaped pulses applied to C(α),C' transfer and C (β),C (aromatic) correlations. J Biomol NMR (1996) 0.99
A role for CD21/CD35 and CD19 in responses to acute septic peritonitis: a potential mechanism for mast cell activation. J Immunol (2000) 0.99
The treatment of acute lymphoedema with pantothenic acid and pyridoxine: an electron microscopical investigation. Lymphology (1969) 0.99
Effects of stimulation and hemicholinium (HC-3) on the fine structure of nerve endings in the superior cervical ganglion of the cat. Brain Res (1971) 0.98
Global cerebral ischemia associated with cardiac arrest in the rat: I. Dynamics of early neuronal changes. J Cereb Blood Flow Metab (1992) 0.98
Recommendations for assessing patient-reported outcomes and health-related quality of life in clinical trials on allergy: a GA(2)LEN taskforce position paper. Allergy (2009) 0.98
Improved neonatal survival following multiple doses of bovine surfactant in very premature neonates at risk for respiratory distress syndrome. Pediatrics (1991) 0.98
Effect of inhibition of adenosine triphosphatase activity on the fine structural organization of the brain capillaries. Nature (1968) 0.97
Specific recommendations for PROs and HRQoL assessment in allergic rhinitis and/or asthma: a GA(2)LEN taskforce position paper. Allergy (2010) 0.97
Further studies on lesions of the oral mucosa using computer-aided analyses of histological features. Br J Cancer (1974) 0.97
Acquired cold urticaria: clinical picture and update on diagnosis and treatment. Clin Exp Dermatol (2007) 0.97
Production of pure primary rat cerebral endothelial cell culture: a comparison of different methods. Neurobiology (Bp) (1997) 0.97
The treatment of experimental lymphedema. Angiologica (1972) 0.96
The role of innate immunity in asthma: leads and lessons from mouse models. Allergy (2007) 0.96
The prelymphatic pathways of the brain as revealed by cervical lymphatic obstruction and the passage of particles. Br J Exp Pathol (1976) 0.96
Severe chronic allergic (and related) diseases: a uniform approach--a MeDALL--GA2LEN--ARIA position paper. Int Arch Allergy Immunol (2012) 0.96
Pattern analysis of human cutaneous mast cell populations by total body surface mapping. Br J Dermatol (2003) 0.95
Experimental blood vascular and lymphatic occlusion in the rabbit ear and the effect of benzopyrones. Arzneimittelforschung (1977) 0.95
EAACI taskforce position paper: evidence for autoimmune urticaria and proposal for defining diagnostic criteria. Allergy (2012) 0.95
Omalizumab--an effective and safe treatment of therapy-resistant chronic spontaneous urticaria. Allergy (2010) 0.94
cAMP-mediated regulation of the permeability in the brain capillaries. Experientia (1975) 0.94
Planar embryos have poor prognosis in terms of blastocyst formation and implantation. Reprod Biomed Online (2012) 0.94